UBS last night upgraded CI&T to Buy from Neutral with a price target of $7, up from $6.80. The firm believes the company is positioned to lead the sector’s recovery and grow above peers. CI&T is well positioned to capture enterprise AI demand while generating cash, the analyst tells investors in a research note. UBS adds that the shares are still discounted versus its own history and peers.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CINT:
